News
China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...
At the same time, biotechnology is opening new paths as an alternative to antibiotics. Countries such as Norway, Chile, and ...
A summary for the SPDR S&P Biotech ETF technical analysis data. Live signals range from strong buy, buy, neutral, sell to strong sell. Assess XBI's detailed technical analysis based on the buy/sell ...
Endogenous intracellular allosteric modulators of GPCRs remain largely unexplored, with limited binding and phenotype data available. This gap arises from the lack of robust computational methods for ...
AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...
The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, Massachusetts ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results